These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

771 related articles for article (PubMed ID: 23148932)

  • 1. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
    Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
    Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pattern and risk factors of recurrence of proximal gastric cancer after curative resection.
    Li F; Zhang R; Liang H; Liu H; Quan J
    J Surg Oncol; 2013 Feb; 107(2):130-5. PubMed ID: 22949400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.
    Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS
    J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic study of node-negative advanced gastric cancer and analysis of factors predicting its recurrence and prognosis.
    Chou HH; Kuo CJ; Hsu JT; Chen TH; Lin CJ; Tseng JH; Yeh TS; Hwang TL; Jan YY
    Am J Surg; 2013 Jun; 205(6):623-30. PubMed ID: 23036602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
    Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
    Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it reasonable to treat early gastric cancer with signet ring cell histology by endoscopic resection? Analysis of factors related to lymph-node metastasis.
    Park JM; Kim SW; Nam KW; Cho YK; Lee IS; Choi MG; Chung IS; Song KY; Park CH; Jung CK
    Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1132-5. PubMed ID: 19369881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer.
    Yamashita K; Sakuramoto S; Katada N; Futawatari N; Moriya H; Hirai K; Kikuchi S; Watanabe M
    Hepatogastroenterology; 2009; 56(89):276-81. PubMed ID: 19453074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different patterns of recurrence in gastric cancer depending on Lauren's histological type: longitudinal study.
    Marrelli D; Roviello F; de Manzoni G; Morgagni P; Di Leo A; Saragoni L; De Stefano A; Folli S; Cordiano C; Pinto E;
    World J Surg; 2002 Sep; 26(9):1160-5. PubMed ID: 12209247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study.
    Honoré C; Goéré D; Messager M; Souadka A; Dumont F; Piessen G; Elias D; Mariette C;
    Eur J Surg Oncol; 2013 Mar; 39(3):235-41. PubMed ID: 23313257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
    Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
    Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the number of examined lymph nodes in node-negative gastric adenocarcinoma.
    Hsu JT; Lin CJ; Sung CM; Yeh HC; Chen TH; Chen TC; Chiang KC; Yeh TS; Hwang TL; Jan YY
    Eur J Surg Oncol; 2013 Nov; 39(11):1287-93. PubMed ID: 23973513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymph node metastasis and the extent of lymph node dissection for gastric cancer: report of 326 cases].
    Wan Y; Pan Y; Liu Y; Wang Z; Ye J; Huang S
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):752-5. PubMed ID: 11832155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing outcome in gastric cancer involving muscularis and subserosal layer.
    Fotia G; Marrelli D; De Stefano A; Pinto E; Roviello F
    Eur J Surg Oncol; 2004 Nov; 30(9):930-4. PubMed ID: 15498636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategy for patients with pN0 gastric carcinoma.
    Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
    J Surg Oncol; 2006 Sep; 94(3):212-9. PubMed ID: 16900514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
    Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery.
    Sun Z; Xu YY; Wang ZN; Zhu Z; Zhang H; Huang BJ; Xu Y; Chen JQ; Xu HM
    Ann Surg Oncol; 2011 Apr; 18(4):1068-80. PubMed ID: 21293933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of minimally invasive treatment for early gastric cancer.
    Hyung WJ; Cheong JH; Kim J; Chen J; Choi SH; Noh SH
    J Surg Oncol; 2004 Mar; 85(4):181-5; discussion 186. PubMed ID: 14991872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
    J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.